In Reply: We appreciate Mr Maish's comments
about our work and the important issue of quality of life (QOL). We found
that only the sickest patients with CF had a survival benefit from lung transplantation.
To answer Maish's specific question, we previously examined the apparent superior
survival of transplanted patients from group 1 compared with groups 2 and
3 (Figure 1 in our article) and found no statistical difference.
The greater issue is his concern that physicians might lose sight of
the toll that CF has on QOL. The principle primum non nocere (first, do no
harm) requires physicians to consider risks before recommending any procedure.
Our study provides the first estimate of survival risks and benefits of lung
transplantation for patients with CF stratified by predicted survival. We
focused on survival because it is an indisputable end point for measuring
the benefit of therapy.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.